Jazz Pharma Bulls Gain Traction as Shorts Retreat Before Q1 Print
Jazz Pharmaceuticals heads into its May 6 Q1 earnings report with short sellers meaningfully on the back foot after a sharp squeeze in late April. The short interest story has been the defining positioning move of the…